Chemoinformaics analysis of Chrysanthenyl angelate
| Molecular Weight | 234.339 | nRot | 2 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 10 |
| Exact Molecular Weight | 234.162 | nRing | 3 |
| Solubility: LogS | -4.566 | nHRing | 0 |
| Solubility: LogP | 4.15 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 41.3234 |
| nHD | 0 | BPOL | 24.6746 |
| QED | 0.415 |
| Synth | 4.748 |
| Natural Product Likeliness | 3.047 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.587 |
| Pgp-sub | 0.002 |
| HIA | 0.011 |
| CACO-2 | -4.434 |
| MDCK | 0.0000175 |
| BBB | 0.303 |
| PPB | 0.908299 |
| VDSS | 1.927 |
| FU | 0.0932019 |
| CYP1A2-inh | 0.344 |
| CYP1A2-sub | 0.639 |
| CYP2c19-inh | 0.765 |
| CYP2c19-sub | 0.854 |
| CYP2c9-inh | 0.763 |
| CYP2c9-sub | 0.495 |
| CYP2d6-inh | 0.421 |
| CYP2d6-sub | 0.304 |
| CYP3a4-inh | 0.585 |
| CYP3a4-sub | 0.381 |
| CL | 13.194 |
| T12 | 0.104 |
| hERG | 0.012 |
| Ames | 0.007 |
| ROA | 0.244 |
| SkinSen | 0.201 |
| Carcinogencity | 0.043 |
| EI | 0.081 |
| Respiratory | 0.946 |
| NR-Aromatase | 0.008 |
| Antiviral | Yes |
| Prediction | 0.882584 |